Top Biotech companies by P/S Ratio
Browse the best P/S Ratio Biotech companies in the world. Based on the financial data from 9 Biotech stocks the average price to sales ratio is 6.83 in 2024.
20 Jun 2024, 19:28 UTCCompanies: 9
Sort by:
Sort by:
๐ฉ๐ฐ1 | $143.63 | 0.52% | 19.10 | 41.22% | Outperform S&P500 YTD Benchamark | โ๏ธ Healthcare | 0.72% | |
๐บ๐ธ2 | $1,002.95 | 0.00% | 8.19 | 14.77% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฎ๐ณ3 | $18.16 | 0.23% | 7.81 | 20.27% | Outperform S&P500 YTD Benchamark | ๐ Pharma | 0.69% | |
๐ฏ๐ต4 | $36.86 | -0.70% | 7.39 | 46.83% | Outperform S&P500 YTD Benchamark | ๐ Pharma | 0.61% | |
๐บ๐ธ5 | $113.68 | -0.71% | 6.82 | -10.49% | Underperform S&P500 YTD Benchamark | ๐ Real estate | 1.09% | |
๐บ๐ธ6 | $73.97 | -0.72% | 4.48 | 4.12% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐จ๐ญ7 | $105.85 | 0.65% | 4.27 | 9.70% | Underperform S&P500 YTD Benchamark | ๐ Pharma | 3.33% | |
๐ฏ๐ต8 | $10.07 | 0.35% | 1.85 | -7.84% | Underperform S&P500 YTD Benchamark | ๐ Pharma | 4.10% | |
๐ฏ๐ต9 | $27.04 | 0.21% | 1.60 | 3.09% | Underperform S&P500 YTD Benchamark | ๐ Pharma | 4.34% |